Renal AA Amyloidosis in Patients with Type 2 Diabetes Mellitus
Background: Type 2 diabetes mellitus (T2DM) is the leading cause of chronic kidney disease and a major cause of cardiovascular disease (CVD) mortality. Inflammation is closely involved in the pathogenesis of T2DM, and reactive amyloidosis occurs in the presence of chronic inflammation. We hypothesiz...
Main Authors: | Ramón Díez, Magdalena Madero, Gerardo Gamba, Juan Soriano, Virgilia Soto |
---|---|
Format: | Article |
Language: | English |
Published: |
Karger Publishers
2014-07-01
|
Series: | Nephron Extra |
Subjects: | |
Online Access: | http://www.karger.com/Article/FullText/363625 |
Similar Items
-
Suppression of COX-2/PGE2 levels by carbazole-linked triazoles via modulating methylglyoxal-AGEs and glucose-AGEs – induced ROS/NF-κB signaling in monocytes
by: Basha, F.Z, et al.
Published: (2022) -
RAGE Mediates Cholesterol Efflux Impairment in Macrophages Caused by Human Advanced Glycated Albumin
by: Adriana Machado-Lima, et al.
Published: (2020-10-01) -
GS-E3D, a new pectin lyase-modified red ginseng extract, inhibited diabetes-related renal dysfunction in streptozotocin-induced diabetic rats
by: Chan-Sik Kim, et al.
Published: (2017-08-01) -
Digestibility of Bovine Serum Albumin and Peptidomics of the Digests: Effect of Glycation Derived from α-Dicarbonyl Compounds
by: Bulei Sheng, et al.
Published: (2018-03-01) -
The Genotoxic and Pro-Apoptotic Activities of Advanced Glycation End-Products (MAGE) Measured with Micronuclei Assay Are Inhibited by Their Low Molecular Mass Counterparts
by: Monika Czech, et al.
Published: (2021-05-01)